Item 5. Other Information

During the fiscal quarter ended April 3, 2026, none of our Directors or officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K, except as follows:

Jennifer K. Mann, Executive Vice President and President, North America operating unit, adopted a Rule 10b5-1 trading arrangement on March 6, 2026 for the potential sale of up to 50,000 shares of common stock of the Company and the potential exercise of vested stock options and the associated sale of up to 273,984 shares of common stock of the Company, subject to certain conditions. The arrangement’s expiration date is March 5, 2027, or such earlier date upon which all transactions are completed.

James Quincey, Chairman of the Board of Directors, adopted a Rule 10b5-1 trading arrangement on March 5, 2026 for the potential exercise of vested stock options and the associated sale of up to 971,383 shares of common stock of the Company, subject to certain conditions. The arrangement’s expiration date is March 5, 2028, or such earlier date upon which all transactions are completed.

These trading plans were adopted during an open trading window.